Cargando…

Immunobiologicals in dermatology()

Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Dimitri Luz Felipe da, Secamilli, Elisa Nunes, Beleli, Mariana Valbon, Massuda, Juliana Yumi, Franca, Andrea F.E.C., Magalhães, Renata F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133248/
https://www.ncbi.nlm.nih.gov/pubmed/35314083
http://dx.doi.org/10.1016/j.abd.2021.05.016
_version_ 1784713524192215040
author Silva, Dimitri Luz Felipe da
Secamilli, Elisa Nunes
Beleli, Mariana Valbon
Massuda, Juliana Yumi
Franca, Andrea F.E.C.
Magalhães, Renata F.
author_facet Silva, Dimitri Luz Felipe da
Secamilli, Elisa Nunes
Beleli, Mariana Valbon
Massuda, Juliana Yumi
Franca, Andrea F.E.C.
Magalhães, Renata F.
author_sort Silva, Dimitri Luz Felipe da
collection PubMed
description Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is important for dermatologists to have knowledge of the medications approved in Brazil, for the best management of dermatoses, in addition to the fact that they represent hope for improvement in patients with chronic diseases.
format Online
Article
Text
id pubmed-9133248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-91332482022-05-26 Immunobiologicals in dermatology() Silva, Dimitri Luz Felipe da Secamilli, Elisa Nunes Beleli, Mariana Valbon Massuda, Juliana Yumi Franca, Andrea F.E.C. Magalhães, Renata F. An Bras Dermatol Continuing Medical Education Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is important for dermatologists to have knowledge of the medications approved in Brazil, for the best management of dermatoses, in addition to the fact that they represent hope for improvement in patients with chronic diseases. Sociedade Brasileira de Dermatologia 2022 2022-03-18 /pmc/articles/PMC9133248/ /pubmed/35314083 http://dx.doi.org/10.1016/j.abd.2021.05.016 Text en © 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Continuing Medical Education
Silva, Dimitri Luz Felipe da
Secamilli, Elisa Nunes
Beleli, Mariana Valbon
Massuda, Juliana Yumi
Franca, Andrea F.E.C.
Magalhães, Renata F.
Immunobiologicals in dermatology()
title Immunobiologicals in dermatology()
title_full Immunobiologicals in dermatology()
title_fullStr Immunobiologicals in dermatology()
title_full_unstemmed Immunobiologicals in dermatology()
title_short Immunobiologicals in dermatology()
title_sort immunobiologicals in dermatology()
topic Continuing Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133248/
https://www.ncbi.nlm.nih.gov/pubmed/35314083
http://dx.doi.org/10.1016/j.abd.2021.05.016
work_keys_str_mv AT silvadimitriluzfelipeda immunobiologicalsindermatology
AT secamillielisanunes immunobiologicalsindermatology
AT belelimarianavalbon immunobiologicalsindermatology
AT massudajulianayumi immunobiologicalsindermatology
AT francaandreafec immunobiologicalsindermatology
AT magalhaesrenataf immunobiologicalsindermatology